Çeşitli Klinik Örneklerden İzole Edilen Stenotrophomonas maltophilia Suşlarının Dağılımı ve Antimikrobiyal Duyarlılıkları: 8 Yılık Çalışma

The aim of this study was to investigate the distribution and antimicrobial susceptibility of S. maltophilia isolates obtained from various clinical samples in our hospital for a period of eight years. Bacterial identification and antibiotic susceptibility were performed with routine conventional mi...

Full description

Saved in:
Bibliographic Details
Published in:Dicle tıp dergisi 2021-03, Vol.48 (1), p.147-152
Main Authors: Bahçeci, İlkay, Kostakoǧlu, Uǧur, Duran, Ömer Faruk, Yıldız, İlknur Esen, Dilek, Aziz Ramazan
Format: Article
Language:Turkish
Subjects:
Antimicrobial agents
Drug resistance
Nosocomial infections
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The aim of this study was to investigate the distribution and antimicrobial susceptibility of S. maltophilia isolates obtained from various clinical samples in our hospital for a period of eight years. Bacterial identification and antibiotic susceptibility were performed with routine conventional microbiological methods and the VITEK 2 compact automated system (BioMerieux, France). Results: While S. maltophilia was most frequently isolated in intensive care units, from a total of 50 samples (33.5%), the rate was 0.6% (1 sample) the cardio vascular surgery service and pediatrics services. 85 (57%) of the samples were respiratory tract isolates (tracheal aspirate, lavage, sputum) with at least 1 (0.6%) pleural and joint fluid. Antimikrobiyal duyarlılıǧının tespit edilmesinde 2011-2016 yılları arasında Clinical Laboratory Standards Institute (CLSI)- 2011 ve (CLSI) tarafından S. maltophilia izolatları için tavsiye edilen A grubu antimikrobiyal olarak trimetoprim-sulfametoksazol (TMPSXT), B grubu antimikrobiyal olarak da levofloksasin ve seftazidim alınmış iken 2017-2019 tarihleri arasında izole edilen suşlarda European Committee on Antimicrobial Susceptibility Testing (EUCAST) 2017 referans olarak kabul edilmiş ve yine aynı şekilde önerilen A grubu antimikrobiyal olarak (TMPSXT), B grubu antimikrobiyal olarak da levofloksasin ve seftazidim alınmıştır.
ISSN:1300-2945
1308-9889
DOI:10.5798/dicletip.887633